500 episodes

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

Citeline Podcasts Citeline

    • Business
    • 4.4 • 25 Ratings

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

    Scrip's Five Must-Know Things - 26 February 2024

    Scrip's Five Must-Know Things - 26 February 2024

    Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Bayer takes strategic steps to cut debt; AbbVie confirms internal appointment as CEO; another RIPK1 setback for Denali/Sanofi; new biotech reality in China; and ex-Daiichi Sankyo CEO shares insights into tough decisions.
    https://scrip.citeline.com/SC149846/Quick-Listen-Scrips-Five-MustKnow-Things

    • 14 min
    Drug Fix: US FDA And Psychedelic Drugs, Aduhelm Clinical Trial Data, Adcomm Candidates

    Drug Fix: US FDA And Psychedelic Drugs, Aduhelm Clinical Trial Data, Adcomm Candidates

    Pink Sheet reporters and editors discuss the FDA’s approach to psychedelic drugs (:25), whether postmarket clinical trial data from the Alzheimer’s drug Aduhelm will be published (16:32), and the FDA offering more time to find candidates for its new Genetic Metabolic Diseases Advisory Committee (27:19).

    More On These Topics From The Pink Sheet

    Lykos’ MDMA NDA Leads Upcoming Tests Of US FDA’s Psychedelics Draft Guidance: https://pink.citeline.com/PS149813/Lykos-MDMA-NDA-Leads-Upcoming-Tests-Of-US-FDAs-Psychedelics-Draft-Guidance

    For Psychedelics, US FDA Is Open To Creative Thinking But Firm On Approval Standards: https://pink.citeline.com/PS149812/For-Psychedelics-US-FDA-Is-Open-To-Creative-Thinking-But-Firm-On-Approval-Standards

    A Visual Trip Through The Psychedelic Pipeline: https://pink.citeline.com/PS149831/A-Visual-Trip-Through-The-Psychedelic-Pipeline

    Aduhelm’s Post-Marketing Studies: At Least One More Data Dump Likely Required By NIH: https://pink.citeline.com/PS149826/Aduhelms-Post-Marketing-Studies-At-Least-One-More-Data-Dump-Likely-Required-By-NIH

    New US FDA Genetic Metabolic Adcomm Needs More Candidates: https://pink.citeline.com/PS149819/New-US-FDA-Genetic-Metabolic-Adcomm-Needs-More-Candidates

    • 32 min
    AESGP’s 60th Birthday Celebrations In 2024 Including Annual Meeting, With Jurate Švarcaite

    AESGP’s 60th Birthday Celebrations In 2024 Including Annual Meeting, With Jurate Švarcaite

    The Association of the European Self-Care Industry celebrates its 60th birthday this year. In this episode, we catch up with AESGP director general, Jurate Švarcaite, to find out how the association will mark the occasion, including at this year’s Annual Meeting in Brussels in June. AESGP Annual Meetings are an excellent way to find out what the key issues and trends are impacting the European consumer health industry, and this one will be no different. We talk through some of the key themes of this year’s conference. Sustainability continues to be a mega-trend, closely followed by digitalization and artificial intelligence. With its wide-ranging footprint across OTC medicines, food supplements and self-care medical devices sectors, the consumer health industry is facing an avalanche of regulations, and the AESGP continues to be an effective advocate for its stakeholders, alongside adjacent industry partners.

    • 40 min
    Drug Fix: Price Negotiation Suit Tossed, Drug Shortage Probe, FDA-Approved Marijuana

    Drug Fix: Price Negotiation Suit Tossed, Drug Shortage Probe, FDA-Approved Marijuana

    Pink Sheet reporters and editors discuss the dismissal of PhRMA’s suit challenging the Medicare price negotiation provisions (:30), the US FTC and HHS investigation of drug shortages (12:01), and the potential for FDA-approved marijuana products (23:47).

    More On These Topics From The Pink Sheet

    PhRMA’s Lawsuit Against Medicare Trips Over ‘Administrative Remedy’ Standard; Will Others? https://pink.citeline.com/PS149791/PhRMAs-Lawsuit-Against-Medicare-Trips-Over-Administrative-Remedy-Standard-Will-Others

    FTC, HHS Probe GPO Contracting Practices As Source Of Generic Drug Shortages: https://pink.citeline.com/PS149790/FTC-HHS-Probe-GPO-Contracting-Practices-As-Source-Of-Generic-Drug-Shortages

    Prescription Marijuana? FDA Rescheduling Memo Sets Stage To Test Whether There’s A Viable Market: https://pink.citeline.com/PS149781/Prescription-Marijuana-FDA-Rescheduling-Memo-Sets-Stage-To-Test-Whether-Theres-A-Viable-Market

    • 37 min
    Drug Fix: State Of The Generic Industry, US FDA Under Second Trump Term, Inspections And Shortages

    Drug Fix: State Of The Generic Industry, US FDA Under Second Trump Term, Inspections And Shortages

    Pink Sheet reporter and editors discuss the issues and concerns raised during a major generic industry conference (:42), former FDA Commissioner Scott Gottlieb’s views on what a second Trump term as president would mean for the agency (13:54), and congressional hearings on FDA foreign manufacturing facility inspections and drug shortages (23:51).

    More On These Topics From The Pink Sheet

    ‘We Did Too Good Of A Job’ On Lowering Prices: Sandoz’s Haruvi Discusses Generic Sustainability: https://pink.citeline.com/PS149745/We-Did-Too-Good-Of-A-Job-On-Lowering-Prices-Sandozs-Haruvi-Discusses-Generic-Sustainability

    Blue Shield Of California’s Pharmacy Benefit Overhaul Could Still See Boost From Transparency Legislation: https://pink.citeline.com/PS149751/Blue-Shield-Of-Californias-Pharmacy-Benefit-Overhaul-Could-Still-See-Boost-From-Transparency-Legislation

    Gottlieb: FDA Would Be Subject To More White House Control Under A Second Trump Term: https://pink.citeline.com/PS149737/Gottlieb-FDA-Would-Be-Subject-To-More-White-House-Control-Under-A-Second-Trump-Term

    Congress Explores Plans For Catching Up On US FDA Foreign Inspections: https://pink.citeline.com/PS149744/Congress-Explores-Plans-For-Catching-Up-On-US-FDA-Foreign-Inspections

    Environmental Regulations May Create Barriers To Onshoring More Rx Manufacturing: https://pink.citeline.com/PS149749/Environmental-Regulations-May-Create-Barriers-To-Onshoring-More-Rx-Manufacturing

    • 36 min
    China Biotech Podcast (Chinese and English Language) - February 2024

    China Biotech Podcast (Chinese and English Language) - February 2024

    Brian Yang, Dexter Yan and UK-based Kevin Grogan discuss Shanghai's new policy, draft US Biosecure bill, and multinationals AstraZeneca and Sanofi executives' views on China and Chinese innovation, along with other challenges.
    https://scrip.citeline.com/SC149758/China-Biotech-Podcast-Shanghai-Policy-US-Draft-Biosecure-Bill-MNCs-China-Strategy

    • 37 min

Customer Reviews

4.4 out of 5
25 Ratings

25 Ratings

Azdog1 ,

My Top Source for Industry News

I use all of Informa's sources of information, but in a busy world, the podcasts keep me most updated on the issues that affect my work as a healthcare consultant. I can't keep on top of everything, but with my podcasts loaded up, I can hear great analysis on what's most relevant today while running or doing chores around the house.

Jiayi.C ,

Too many “uh” during the conversation

Too many “uh” and broken sentences. I find it so painful to follow

Odie8387 ,

Good information, bad delivery

Often times a podcast with very good information, but quite poorly delivered. As someone who regularly conducts market research interviews via telephone and web, I’m very familiar with reading through far too many colloquialisms, filler words, and trite expressions. Words and phrases such as “right “and you know” “um” “and” “uh” make it painful to listen to in any regular basis.

Top Podcasts In Business

NerdWallet Personal Finance
Ramsey Network
Money News Network
NPR
Dan Fleyshman
Hala Taha | YAP Media Network

You Might Also Like

STAT
Matt Pillar
Timmerman Report
Pharma and BioTech News
Andreessen Horowitz
Tradeoffs